These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 36303458)
1. Lipopolysaccharide-induced hypothalamic inflammation in cancer cachexia-anorexia is amplified by tumour-derived prostaglandin E2. Li X; Holtrop T; Jansen FAC; Olson B; Levasseur P; Zhu X; Poland M; Schalwijk W; Witkamp RF; Marks DL; van Norren K J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):3014-3027. PubMed ID: 36303458 [TBL] [Abstract][Full Text] [Related]
2. Involvement of cyclooxygenase-derived prostaglandin E2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolysaccharide. Jaworek J; Bonior J; Tomaszewska R; Jachimczak B; Kot M; Bielański W; Pawlik WW; Sendur R; Stachura J; Konturek PC; Konturek SJ J Physiol Pharmacol; 2001 Mar; 52(1):107-26. PubMed ID: 11321505 [TBL] [Abstract][Full Text] [Related]
3. Peripheral-central network analysis of cancer cachexia status accompanied by the polarization of hypothalamic microglia with low expression of inhibitory immune checkpoint receptors. Suda Y; Nakamura K; Matsuyama F; Hamada Y; Makabe H; Narita M; Nagumo Y; Mori T; Kuzumaki N; Narita M Mol Brain; 2024 Apr; 17(1):20. PubMed ID: 38685046 [TBL] [Abstract][Full Text] [Related]
4. Establishment and characterization of a novel murine model of pancreatic cancer cachexia. Michaelis KA; Zhu X; Burfeind KG; Krasnow SM; Levasseur PR; Morgan TK; Marks DL J Cachexia Sarcopenia Muscle; 2017 Oct; 8(5):824-838. PubMed ID: 28730707 [TBL] [Abstract][Full Text] [Related]
5. The role of hypothalamic inflammation, the hypothalamic-pituitary-adrenal axis and serotonin in the cancer anorexia-cachexia syndrome. van Norren K; Dwarkasing JT; Witkamp RF Curr Opin Clin Nutr Metab Care; 2017 Sep; 20(5):396-401. PubMed ID: 28708669 [TBL] [Abstract][Full Text] [Related]
6. R-ketorolac ameliorates cancer-associated cachexia and prolongs survival of tumour-bearing mice. Chrysostomou SE; Eder S; Pototschnig I; Mayer AL; Derler M; Mussbacher M; Schauer S; Zhang D; Yan D; Liu G; Hoefler G; Weichhart T; Vesely PW; Zhang L; Schweiger M J Cachexia Sarcopenia Muscle; 2024 Apr; 15(2):562-574. PubMed ID: 38302863 [TBL] [Abstract][Full Text] [Related]
7. Baicalin, a component of Scutellaria baicalensis, alleviates anorexia and inhibits skeletal muscle atrophy in experimental cancer cachexia. Li B; Wan L; Li Y; Yu Q; Chen P; Gan R; Yang Q; Han Y; Guo C Tumour Biol; 2014 Dec; 35(12):12415-25. PubMed ID: 25195133 [TBL] [Abstract][Full Text] [Related]
9. Dietary n-3 fatty acids differentially affect sickness behavior in mice during local and systemic inflammation. Kozak W; Soszynski D; Rudolph K; Conn CA; Kluger MJ Am J Physiol; 1997 Apr; 272(4 Pt 2):R1298-307. PubMed ID: 9140033 [TBL] [Abstract][Full Text] [Related]
10. Lactobacillus fermentum ZYL0401 Attenuates Lipopolysaccharide-Induced Hepatic TNF-α Expression and Liver Injury via an IL-10- and PGE2-EP4-Dependent Mechanism. Jin P; Chen Y; Lv L; Yang J; Lu H; Li L PLoS One; 2015; 10(5):e0126520. PubMed ID: 25978374 [TBL] [Abstract][Full Text] [Related]
11. DXXK exerts anti-inflammatory effects by inhibiting the lipopolysaccharide-induced NF-κB/COX-2 signalling pathway and the expression of inflammatory mediators. Yu Y; Li X; Qu L; Chen Y; Dai Y; Wang M; Zou W J Ethnopharmacol; 2016 Feb; 178():199-208. PubMed ID: 26571085 [TBL] [Abstract][Full Text] [Related]
12. C/EBPβ promotes the expression of atrophy-inducing factors by tumours and is a central regulator of cancer cachexia. AlSudais H; Rajgara R; Saleh A; Wiper-Bergeron N J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):743-757. PubMed ID: 35014202 [TBL] [Abstract][Full Text] [Related]
13. Anorexia and cachexia in prostaglandin EP1 and EP3 subtype receptor knockout mice bearing a tumor with high intrinsic PGE2 production and prostaglandin related cachexia. Wang W; Andersson M; Lönnroth C; Svanberg E; Lundholm K J Exp Clin Cancer Res; 2005 Mar; 24(1):99-107. PubMed ID: 15943039 [TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory and antitumoural effects of Uncaria guianensis bark. Urdanibia I; Michelangeli F; Ruiz MC; Milano B; Taylor P J Ethnopharmacol; 2013 Dec; 150(3):1154-62. PubMed ID: 24212077 [TBL] [Abstract][Full Text] [Related]
15. Experimental cancer cachexia: the role of host-derived cytokines interleukin (IL)-6, IL-12, interferon-gamma, and tumor necrosis factor alpha evaluated in gene knockout, tumor-bearing mice on C57 Bl background and eicosanoid-dependent cachexia. Cahlin C; Körner A; Axelsson H; Wang W; Lundholm K; Svanberg E Cancer Res; 2000 Oct; 60(19):5488-93. PubMed ID: 11034092 [TBL] [Abstract][Full Text] [Related]
16. The effect of the anti-inflammatory cytokines interleukin-4 and interleukin-10 on lipopolysaccharide-stimulated production of prostaglandin E2 by cultured human decidual cells. Simhan HN; Chura JC; Rauk PN J Reprod Immunol; 2004 Dec; 64(1-2):1-7. PubMed ID: 15596223 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of microsomal prostaglandin E-synthase-1 (mPGES-1) selectively suppresses PGE Martin EM; Jones SL Vet Immunol Immunopathol; 2017 Oct; 192():33-40. PubMed ID: 29042013 [TBL] [Abstract][Full Text] [Related]
18. Cancer cachexia induces morphological and inflammatory changes in the intestinal mucosa. Costa RGF; Caro PL; de Matos-Neto EM; Lima JDCC; Radloff K; Alves MJ; Camargo RG; Pessoa AFM; Simoes E; Gama P; Cara DC; da Silva ASF; O Pereira W; Maximiano LF; de Alcântara PSM; Otoch JP; Trinchieri G; Laviano A; Muscaritoli M; Seelaender M J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1116-1127. PubMed ID: 31307125 [TBL] [Abstract][Full Text] [Related]
19. TRIF is a key inflammatory mediator of acute sickness behavior and cancer cachexia. Burfeind KG; Zhu X; Levasseur PR; Michaelis KA; Norgard MA; Marks DL Brain Behav Immun; 2018 Oct; 73():364-374. PubMed ID: 29852290 [TBL] [Abstract][Full Text] [Related]
20. Dose-dependent immunomodulatory effects of acetylsalicylic acid and indomethacin in human whole blood: potential role of cyclooxygenase-2 inhibition. Härtel C; von Puttkamer J; Gallner F; Strunk T; Schultz C Scand J Immunol; 2004 Oct; 60(4):412-20. PubMed ID: 15379866 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]